Augustine Asset Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
SAM
GA
PFS
AIP
ONB
VFM
QCM
ERP
BIAS
Augustine Asset Management's NVO Position: Q2 2026 in Review
Augustine Asset Management reduced its Novo Nordisk (NVO) stake by 2.2% in Q2 2026, selling an estimated $32.3K and leaving 34,042 shares worth $1.63M. The position accounts for 0.33% of the portfolio, ranked #39.
Augustine Asset Management first reported a position in NVO in Q1 2015 and has held it in 13 quarters since. The position peaked at $3.99M in Q4 2015. 205 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Augustine Asset Management held 34,042 shares of Novo Nordisk worth $1.63M as of Q2 2026.
- Augustine Asset Management sold 751 Novo Nordisk shares in Q2 2026, an estimated $32.3K.
- Novo Nordisk made up 0.33% of Augustine Asset Management's portfolio in Q2 2026, its #39 holding.
- Augustine Asset Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 13 quarters since.
- Augustine Asset Management's Novo Nordisk position peaked at $3.99M in Q4 2015.
- 205 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Augustine Asset Management's 13F filing for Q2 2026, filed 13 Jul 2026.